|
STEM CELL MARKET REPORTS
Claim market intelligence specific for the stem cell sector. Learn profitable opportunities your company can pursue. Discover trends, metrics and little known industry data that separate the top 2% of stem cell companies from the rest of the marketplace. Because we believe all customers should be repeat customers, all BioInformant products are backed by a progressive 60-Day Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product. To serve of range of industry and government clients, reports can be purchased directly through this site, or alternatively, by fax, telephone, email, or purchase order. Click here for more information on purchasing.
The cord blood banking industry is one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide. Now, there are 485 cord blood banks worldwide. The industry report reveals strategies for dominating the cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature of this report is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions. The report is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into this market. It differs from "The Complete U.S. 2012-13 Cord Blood Banking Industry Report," in that it is a strategic overview of how to profit from the global cord blood banking market, rather than from the U.S. markets alone.
Discover the trends, strategies, and behaviors that separates the top 2% of United States cord blood banks from the rest of the marketplace. What is causing rapid double digit growth in the cord blood banking market? What distinguishes fast-growth from flat-growth companies? And, how do you protect yourself from the pack of competitors entering your market? A distinctive feature of this report is a survey of U.S. expectant parents who reveal their deepest fears, expectations, and critical factors influencing buying decisions. Discover how U.S. parents make decisions about cord blood banking and how to sell your services without price discounting or worrying they will go to your competition. This industry report is designed for U.S. cord blood banks and investors entering the American market, as it is focused exclusively on strategies for profit and growth within the United States cord blood banking market. Don’t forget you’ll get a no questions asked, 60-day full-satisfaction money-back guarantee when claim it today.
Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights.
Whether you already supply stem cell research products or you wish to expand your product line, you’ll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition. This report – published in December 2012 – shows you how to do just that. Helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines. The report also includes an End-User Survey (Scientist Panel) that contains opinions from over 400 stem cell researchers.
Put simply, this report will help you understand and profit from the Mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research. Updated to reflect the most current trends and including a five year market projection, this report focuses on the advances in MSC research. In 124 pages you’ll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis. If you’re looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. And buy today to get our 60-day money-back guarantee.
Starting with their discovery in 2006, a large and thriving market has grown into existence for iPSC products. iPSC are now sold by 53.4% of U.S. research product companies and 38.7% of research product companies worldwide. Annual growth in the number of iPSC research product sold worldwide is growing at a rate of 14.7% per year. In addition, 22% of all stem cell researchers now report having using iPSCs within a research project. It is clear that iPSCs represent a lucrative product market for research supply companies to pursue - and this report is your guide to claiming maximal profits from this sector. The most distinctive feature of this report is a survey of 293 iPSC researchers (181 U.S. / 112 International). It reveals the wants/needs, technical preferences, and key factors influencing buying decisions among iPSC researchers. Remember, this product has a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
However, the patent landscape is complicated. This report explores the IP environment affecting the development of hESC products, giving clear guidance for research product supply companies. The report also gives you a wealth of valuable market data to ensure you develop and market products in this stem cell sector effectively. Understand historical and future growth projections, view competitive analysis of providers of hESC research tools and a breakdown of product categories. Learn this and much more in this leading 126-page market intelligence report. And yes, that’s right, it too comes with a 60-day, no questions asked, money-back guarantee.
With the possibility of treating and curing chronic neurological diseases such as Parkinson’s and Alzheimer's, the interest in neuronal stem and progenitor cells has become profound in the research community. And this means huge opportunities for your stem cell product line. This 113 page market intelligence report gives you detailed guidance to strategically position neural stem cell (NSC) research products, including cells, kits, assays, and related media and agents. Understand advances in research and how that impacts the products scientists need. Explore the competitive environment for NSC research products. Use the 5-year growth and trend analysis to develop and market the most profitable products. With a 60-day money-back guarantee and the opportunity to dominate the NSC research product market, we think you should read more.
Copyright © 2012 BioInformant Worldwide, L.L.C. All rights reserved. |
As human embryonic stem cells (hESC) can develop into 200 different cell types, they provide tremendous therapeutic potential.
| Home | Company | Our Clients | Contact Us |
60-Day Money Back Guarantee:
All BioInformant products come with a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
